Skip to main content
Main navigation
About pCPA
Who We Are
Governance
Strategic Plan
Reports
What's New at the pCPA
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Atectura Breezhaler (indacaterol /mometasone furoate)
pCPA File Number:
21340
Negotiation Status:
Concluded with an LOI
Indication(s):
Asthma
Sponsor/Manufacturer:
Valeo Pharma Inc.
CADTH Project Number:
SR0646-000
pCPA Engagement Letter Issued:
2021-06-23
Negotiation Process Concluded:
2021-09-30